increased risk of bradycardia and fainting in patients taking cholinesterase inhibitors
July 2009
You'll start hearing about an increased risk of bradycardia and fainting in patients taking cholinesterase inhibitors...Aricept, Exelon, and Razadyne.
TV ads imply that children who love their aging parents should get them on one of these drugs soon after dementia symptoms appear...to extend the parents' quality time.
It's a balance between risks and benefits.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote